Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Breast cancer genetics and risk assessment 101: What women's health care providers need to know | Synapse
March 3, 2026
Breast cancer genetics and risk assessment 101: What women's health care providers need to know
BR
Barbara E. Ruddy
Mayo Clinic in Arizona
PP
Patress Persons
Mayo Clinic in Arizona
ED
Elizabeth Dacek
Mayo Clinic in Arizona
Puntos clave
Breast cancer genetics significantly affects risk assessment, indicating that provider awareness is crucial.
Understanding biomarkers linked to family history allows for tailored patient management strategies.
Incorporating genetic data improves risk prediction and early detection methods for breast cancer.
Enhanced risk assessment can lead to better screening and prevention practices in women's health care.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Ruddy et al. (Fri,) studied this question.
synapsesocial.com/papers/69a768b3badf0bb9e87e5aae
https://doi.org/https://doi.org/10.1016/j.maturitas.2026.108865